Phase I/IIa Clinical Evaluation of AllerT vs Placebo in Subjects Allergic to Birch Pollen

NCT01728519 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

29

Enrollment

INDUSTRY

Sponsor class

Stopped Recruitment was stopped before start of the pollen season

Conditions

Allergic Rhinitis
Allergy

Interventions

DRUG: AllerT SC
DRUG: AllerT ID
DRUG: Placebo SC
DRUG: Placebo ID

Sponsor

Anergis